PATENT CLAIM ANALYSIS

Application Number: 16176352
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-08
Patent Classification: ["424", "001730"]

Abstract:
The present invention provides an in vivo imaging method that facilitates the diagnosis of Acute Lymphoblastic Leukemia (ALL) at an early stage. Early diagnosis is particularly advantageous as a tool to select more aggressive therapy, to estimate the success rate for visualizing ALL at the time of diagnosis.

Claim (Index 28):
The method of  claim 21 , wherein said nucleoside analog is an  18 F nucleoside analog.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 97.0
- Lexical Diversity: 1.23256
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12234478', '11629607', '12448102', '14119539', '13596632']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7029790224474195
- 35 USC 102 Novelty (BERT): 0.4812699796573342
- Combined Prediction Score: 0.6808081181684109
- Mean Citation Score: 129.044966
- Max Citation Score: 130.87474
- Similarity Product: 86.5096714269352

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test